JP2023544249A - リビトール治療 - Google Patents
リビトール治療 Download PDFInfo
- Publication number
- JP2023544249A JP2023544249A JP2023515723A JP2023515723A JP2023544249A JP 2023544249 A JP2023544249 A JP 2023544249A JP 2023515723 A JP2023515723 A JP 2023515723A JP 2023515723 A JP2023515723 A JP 2023515723A JP 2023544249 A JP2023544249 A JP 2023544249A
- Authority
- JP
- Japan
- Prior art keywords
- day
- ribitol
- dose
- comprises administering
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063076761P | 2020-09-10 | 2020-09-10 | |
| US63/076,761 | 2020-09-10 | ||
| PCT/US2021/049677 WO2022056137A1 (en) | 2020-09-10 | 2021-09-09 | Ribitol treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544249A true JP2023544249A (ja) | 2023-10-23 |
| JP2023544249A5 JP2023544249A5 (https=) | 2024-09-11 |
Family
ID=80629815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515723A Pending JP2023544249A (ja) | 2020-09-10 | 2021-09-09 | リビトール治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230364118A1 (https=) |
| EP (1) | EP4210708A4 (https=) |
| JP (1) | JP2023544249A (https=) |
| KR (1) | KR20230069941A (https=) |
| CN (1) | CN117355310A (https=) |
| AU (1) | AU2021338706A1 (https=) |
| CA (1) | CA3191582A1 (https=) |
| IL (1) | IL301088A (https=) |
| MX (1) | MX2023001881A (https=) |
| WO (1) | WO2022056137A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10434113B2 (en) | 2016-12-16 | 2019-10-08 | The Charlotte Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| AU2020283556A1 (en) | 2019-05-28 | 2022-01-06 | The Charlotte-Mecklenburg Hospital Authority D/B/A Atrium Health | Compositions and methods of making ribitol |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245235B2 (en) * | 2016-12-16 | 2019-04-02 | The Charlotte-Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| US20200061092A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
-
2021
- 2021-09-09 AU AU2021338706A patent/AU2021338706A1/en active Pending
- 2021-09-09 IL IL301088A patent/IL301088A/en unknown
- 2021-09-09 WO PCT/US2021/049677 patent/WO2022056137A1/en not_active Ceased
- 2021-09-09 MX MX2023001881A patent/MX2023001881A/es unknown
- 2021-09-09 CN CN202180073484.0A patent/CN117355310A/zh active Pending
- 2021-09-09 US US18/044,747 patent/US20230364118A1/en active Pending
- 2021-09-09 CA CA3191582A patent/CA3191582A1/en active Pending
- 2021-09-09 JP JP2023515723A patent/JP2023544249A/ja active Pending
- 2021-09-09 KR KR1020237010497A patent/KR20230069941A/ko active Pending
- 2021-09-09 EP EP21867600.5A patent/EP4210708A4/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245235B2 (en) * | 2016-12-16 | 2019-04-02 | The Charlotte-Mecklenburg Hospital Authority | Compositions and methods for treating muscular dystrophy and other disorders |
| US20200061092A1 (en) * | 2018-08-24 | 2020-02-27 | The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health | Methods and compositions for treating disorders associated with muscle weakness |
Non-Patent Citations (2)
| Title |
|---|
| NAT COMMUN, vol. 7:11534, JPN6025034027, 2016, ISSN: 0005672264 * |
| NAT COMMUN, vol. 9:3448, JPN6025034028, 2018, ISSN: 0005672263 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3191582A1 (en) | 2022-03-17 |
| AU2021338706A1 (en) | 2023-05-25 |
| CN117355310A (zh) | 2024-01-05 |
| EP4210708A1 (en) | 2023-07-19 |
| EP4210708A4 (en) | 2024-10-23 |
| WO2022056137A1 (en) | 2022-03-17 |
| IL301088A (en) | 2023-05-01 |
| MX2023001881A (es) | 2023-04-03 |
| US20230364118A1 (en) | 2023-11-16 |
| KR20230069941A (ko) | 2023-05-19 |
| WO2022056137A9 (en) | 2022-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6612370B2 (ja) | ポンペ病の処置のための投与計画 | |
| US12427161B2 (en) | Methods for treating and pharmaceutical compositions | |
| CN114929209A (zh) | 肌萎缩侧索硬化的治疗 | |
| CZ292002B6 (cs) | Léčivo pro snížení úmrtnosti způsobené městnavým selháním srdce u savců | |
| CN103974619A (zh) | 治疗法布里病的给药方案 | |
| JP7765970B2 (ja) | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 | |
| BR112019025083A2 (pt) | métodos de tratamento de pacientes portadores de fabry com insuficiência renal | |
| CZ295567B6 (cs) | Tetrahydrolipstatin pro výrobu orálního farmaceutického prostředku pro ošetřování typu II diabetes mellitus | |
| CN117677395A (zh) | 长效glp1/胰高血糖素受体激动剂的剂量方案 | |
| JP2023544249A (ja) | リビトール治療 | |
| US20200061092A1 (en) | Methods and compositions for treating disorders associated with muscle weakness | |
| EP2806878A1 (en) | Treatment of liver conditions | |
| WO2012154779A1 (en) | Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladder | |
| KR20250034995A (ko) | 뉴클레오시드 의약품의 생체이용률을 증가시키는 방법 | |
| RU2653478C2 (ru) | Способ улучшения функции печени | |
| WO2012154892A1 (en) | Combinations of propiverine and salivary stimulants for the treatment of overactive bladder | |
| WO2012154893A1 (en) | Combinations of trospium and salivary stimulants for the treatment of overactive bladder | |
| WO2025212841A1 (en) | Compositions and methods for treating diseases and disorders associated with muscle weakness | |
| HK40112795A (en) | Dosing regimens for the treatment of pompe disease | |
| Boelaert et al. | Antiretroviral treatment | |
| EP2767287B1 (en) | Agent for preventing or treating htlv-i associated myelopathy | |
| TW202604485A (zh) | 患有肝損傷患者肝疾病之治療 | |
| HK40081935A (en) | Treatment of amyotrophic lateral sclerosis | |
| WO2012154778A1 (en) | Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder | |
| WO2012154775A1 (en) | Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230330 |
|
| A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A529 Effective date: 20230426 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20230330 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240903 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240903 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250815 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250826 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251126 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260303 |